We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Astaxanthin Attenuates Neurotoxicity in a Mouse Model of Parkinson’s disease

Astaxanthin Attenuates Neurotoxicity in a Mouse Model of Parkinson’s disease content piece image

Astaxanthin (AXT) is a natural carotenoid with diverse biological activities. Although it is best known as a potent antioxidant, recent work suggests additional mechanisms of action that have the potential to oppose the ongoing pathophysiology of Parkinson’s Disease (PD). For example, AXT has a putative role in modulating microglial activity and preserving mitochondrial function, thus supporting the role of this compound as a neuroprotective agent. Both oxidative stress and inflammation are involved in the progression of many neurodegenerative diseases, therefore, we examined the potential for AXT to reduced neurotoxicity in a toxic model of PD in mice. Here, we show that administration of algae derived AXT mitigated MPTP induced dopamine cell death. After a four week dietary supplementation, AXT treated mice were protected against the loss of tyrosine hydroxylase (TH) positive cells in the substantia nigra (SN) after MPTP exposure (10 mg/kg administered hourly for a total of 40mg/kg) compared to the control diet. This effect of preserved TH immunoreactivity was also observed in the striatum. Furthermore, AXT administration was able to interrupt the neuroinflammatory process known to contribute to neurodegeneration in this model. We demonstrate that AXT neuroprotection was associated with attenuated microglial activation indicated by reduced immunohistochemical detection of IBA-1 in the SN and striatum of AXT treated mice. Taken together, these studies suggest that AXT has neuroprotective property in the CNS against MPTP neurodegeneration.